Kopp Family Office, LLC Neogenomics Inc Transaction History

Kopp Family Office, LLC

$161 Million
Q2 2024

A detailed history of Kopp Family Office, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Kopp Family Office, LLC holds 944,775 shares of NEO stock, worth $13.4 Million. This represents 8.13% of its overall portfolio holdings.

Number of Shares

944,775

Previous 894,509 5.62%

Holding current value

$13.4 Million

Previous $14.1 Million 6.81%

% of portfolio

8.13%

Previous 8.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$13.01 - $15.77 $653,960 - $792,694	50,266 Added 5.62%	944,775 $13.1 Million
Q1 2024 Jun 17, 2024	SELL	$14.06 - $16.79 $5,624 - $6,716	-400 Reduced 0.04%	894,509 $14.1 Million
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $1.77 Million - $3.15 Million	-151,730 Reduced 14.5%	894,909 $14.5 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $504,225 - $740,775	41,500 Added 4.13%	1,046,639 $12.9 Million
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $4.03 Million - $5.67 Million	-285,880 Reduced 22.14%	1,005,139 $16.2 Million
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $2.05 Million - $4.38 Million	-225,294 Reduced 14.86%	1,291,019 $22.5 Million
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $147,060 - $275,196	-22,800 Reduced 1.48%	1,516,313 $14 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $600,504 - $986,324	-76,400 Reduced 4.73%	1,539,113 $13.3 Million
Q2 2022 Aug 16, 2022	BUY	$7.06 - $13.97 $8,825 - $17,462	1,250 Added 0.08%	1,615,513 $13.2 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $23,085 - $67,032	1,900 Added 0.12%	1,614,263 $19.6 Million
Q4 2021 Feb 15, 2022	SELL	$30.49 - $48.49 $5.28 Million - $8.4 Million	-173,242 Reduced 9.7%	1,612,363 $55 Million
Q3 2021 Nov 16, 2021	SELL	$41.66 - $52.52 $9.9 Million - $12.5 Million	-237,750 Reduced 11.75%	1,785,605 $86.1 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $6.58 Million - $9.29 Million	-179,810 Reduced 8.16%	2,023,355 $91.4 Million
Q1 2021 May 17, 2021	SELL	$41.56 - $59.88 $36.4 Million - $52.4 Million	-875,650 Reduced 28.44%	2,203,165 $106 Million
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $5.56 Million - $8.71 Million	-154,200 Reduced 4.77%	3,078,815 $166 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $47.5 Million - $57.8 Million	-1,428,820 Reduced 30.65%	3,233,015 $119 Million
Q2 2020 Aug 17, 2020	SELL	$24.21 - $31.02 $2.54 Billion - $3.26 Billion	-105,073,410 Reduced 95.75%	4,661,835 $144 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $2.54 Billion - $3.26 Billion	105,076,410 Added 2255.42%	109,735,245 $144 Million
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $3.81 Million - $6.42 Million	-185,790 Reduced 3.83%	4,658,835 $129 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $91.9 Million - $145 Million	4,844,625 New	4,844,625 $142 Million

Others Institutions Holding NEO

# of Institutions

277

Shares Held

127M

Call Options Held

581K

Put Options Held

115K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.78B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kopp Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kopp Family Office, LLC with notifications on news.

Account

Kopp Family Office, LLC Neogenomics Inc Transaction History